You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華納藥廠(688799.SH)業績快報:2021年度淨利潤升10.33%至1.6億元
格隆匯 02-23 15:43

格隆匯2月23日丨華納藥廠(688799.SH)發佈2021年度業績快報,實現營業總收入11.47億元,同比增加20.61%;歸屬母公司所有者的淨利潤1.6億元,同比增加10.33%;歸屬於母公司所有者的扣除非經常性損益的淨利潤1.41億元,同比增長11.28%;基本每股收益2.00元。

報吿期內,公司銷售繼續保持增長態勢銷售增長主要來自於膠體果膠鉍制劑等消化類產品、琥珀酸亞鐵片等抗貧血類產品、磷黴素氨丁三醇散等抗感染類產品、吸入用乙酰半胱氨酸溶液等呼吸類產品及嗎替麥考酚酯等原料藥產品的銷售增加

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account